TCTAP A-002 Paclitaxel-coated Balloon Versus Paclitaxel-eluting Stent for the Treatment of Diffuse DES In-stent Restenotic Lesions: A Substudy of PEPCAD China ISR Trial

Ye-Lin Zhao,Jian-An Wang,Bo Xu,Jun-Bo Ge,Run-Lin Gao,Shao-Liang Chen,Jie Qian,Yue-Jing Yang

doi:10.1016/j.jacc.2014.02.005

TCTAP A-002 Paclitaxel-coated Balloon Versus Paclitaxel-eluting Stent for the Treatment of Diffuse DES In-stent Restenotic Lesions: A Substudy of PEPCAD China ISR Trial

Ye-Lin Zhao, Jian-An Wang + Show 6 more

Open Access

https://doi.org/10.1016/j.jacc.2014.02.005

Copy DOI

Journal: Journal of the American College of Cardiology	Publication Date: Apr 1, 2014
License type: publisher-specific-oa

Affiliation: Fu Wai Hospital, Second Affiliated Hospital of Zhejiang University, First Affiliated Hospital of Sun Yat-sen University, Zhongshan Hospital, Fudan University, Sun Yat-sen University, Nanjing Medical University

#Drug-eluting Stent In-stent Restenosis #Paclitaxel-coated Balloon + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Treatment of drug-eluting stent in-stent restenosis (DES-ISR) is still challenging especially in diffuse lesions. The intention of this subgroup analysis is to compare the safety and effectiveness of paclitaxel-coated balloon (PCB) versus paclitaxel-eluting stent (PES) in the treatment of patients

Full Text